Latest Cash Flow News

Moab Minerals is progressing its Manyoni uranium project with a planned JORC-compliant resource estimate and is nearing completion of a key tenement acquisition, while securing fresh funding to support ongoing exploration.

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.

PlaySide Studios has raised $6.6 million through a share placement to bolster its balance sheet ahead of the launch of its new original game, MOUSE, P.I. For Hire. The capital raise includes director participation and an upcoming Share Purchase Plan for existing shareholders.

Magnetic Resources NL has achieved a key milestone with the granting of a mining lease over its flagship Lady Julie North 4 deposit, supported by a feasibility study confirming robust economics and over one million ounces of gold production.

333D Limited reported a 12% increase in quarterly cash receipts from digital asset management contracts, maintaining steady cash flow despite slight operating cash usage. The company’s annual contract revenue surpassed $970,000, reflecting growing traction in healthcare digital services.

AGP Investment Management revamps the WCM Quality Global Growth Fund’s distribution policy, moving from annual to quarterly payouts and setting a minimum 5% annual cash yield to enhance investor income predictability.

Pureprofile Limited reported record FY25 results, achieving 19% revenue growth and launching new AI-driven data solutions to fuel future expansion.

Adriatic Metals reported a 23% rise in silver equivalent production in Q2 2025, driven by a 50% increase in ore milled, while revising full-year guidance lower due to operational constraints. The company also declared commercial production and agreed to a recommended acquisition by Dundee Precious Metals.

Central Petroleum Limited reports a robust 22% increase in full-year revenue for FY25, driven by new gas sale contracts and strong operational cash flows. Production at key fields remains steady despite temporary constraints.

ECS Botanics reports a 20% quarterly surge in direct-to-consumer sales and a record medicinal cannabis harvest, supported by an expanded loan facility to fuel further growth.

Botanix Pharmaceuticals reports a strong commercial ramp-up for Sofdra™, with net revenue jumping from $0.7 million to $4.3 million in one quarter, supported by a $40 million capital raise and a $30 million debt facility.

FINEOS Corporation Holdings PLC reports steady revenue growth and operational efficiencies in Q2 2025, alongside new client contracts in North America that bolster its outlook for positive free cash flow this fiscal year.